Search

Your search keyword '"Kühn MWM"' showing total 12 results

Search Constraints

Start Over You searched for: Author "Kühn MWM" Remove constraint Author: "Kühn MWM" Database MEDLINE Remove constraint Database: MEDLINE
12 results on '"Kühn MWM"'

Search Results

1. Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin.

2. The Menin story in acute myeloid leukaemia-The road to success.

3. Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG).

4. Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.

5. Menin inhibitor ziftomenib (KO-539) synergizes with drugs targeting chromatin regulation or apoptosis and sensitizes acute myeloid leukemia with MLL rearrangement or NPM1 mutation to venetoclax.

6. Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy.

7. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.

8. Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.

9. Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia.

10. Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1 -mutated acute myeloid leukemia receiving gemtuzumab ozogamicin.

11. Next generation epigenetic modulators to target myeloid neoplasms.

12. Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition.

Catalog

Books, media, physical & digital resources